Avecho Biotechnology Investor Relations Material
Latest events
Q1 2025 TU
30 Apr, 2025
H2 2024
7 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avecho Biotechnology Limited
Access all reports
Avecho Biotechnology Limited is an Australian pharmaceutical company focused on drug delivery systems. The company develops proprietary formulations that enhance the solubility and absorption of active pharmaceutical ingredients using lipid-based delivery platforms. Its technologies are applied in human health, animal health, and topical therapeutics. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
AVE
Country
🇦🇺 Australia